Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_provenance.
- befree-2016 importedOn "2016-02-19" NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_provenance.
- NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_assertion wasGeneratedBy ECO_0000203 NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_provenance.
- NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_assertion wasDerivedFrom befree-2016 NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_provenance.
- NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_assertion SIO_000772 24847764 NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_provenance.
- NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_assertion evidence source_evidence_literature NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_provenance.
- NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_assertion description "[A phase I clinical trial of the Ad/PSA vaccine in men with metastatic castrate-resistant prostate cancer demonstrated the safety of the vaccine even at the highest single dose permitted by the FDA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1184301.RAGP3RM5OFK_LfCMyjNLEw1aQJ7Bd_CRJaCcNrvbWfyt4130_provenance.